Lipcar, a prognostic marker for heart failure with reduced ejection fraction
The aim of this project is to develop the long non-coding RNA (lncRNA) LIPCAR as a new diagnostic and prognostic marker for patients with heart failure. In this project, we will measure circulating levels of LIPCAR in blood samples from cohorts of patients with different ranges of heart failure such as MI, cardiomyocyte stress/injury, myocardial inflammation and fibrosis and healthy controls in order to develop a new cardiac biomarker.
- Reference: LIPCAR-HF
- Start date: March 1, 2017
- End date: February 28, 2020
- Funder: Joint Transnational Call ERA-CVD 2016 H2020 e Instituto de Salud Carlos III
- Nature of project: International
Need more information?
If you are interested in learning more about our research, please contact us